About OncoSec Medical
OncoSec Medical is a company based in San Diego (United States) founded in 2011 was acquired by Grand Pharmaceuticals in October 2019.. The company has 26 employees as of December 31, 2022. OncoSec Medical operates in a competitive market with competitors including Jazz Pharmaceuticals, BeiGene, Insitro, BridgeBio and ATAI, among others.
- Headquarter San Diego, United States
- Employees 26 as on 31 Dec, 2022
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Oncosec Medical Incorporated
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$7 M (USD), Post-IPO
Dec 06, 2018
-
Investors
HHS
& 3 more
-
Employee Count
26
as on Dec 31, 2022
-
Acquired by
Grand Pharmaceuticals
(Oct 10, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of OncoSec Medical
OncoSec Medical is a publicly listed company on the OTC with ticker symbol ONCSQ in USA, operating in the Health services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of OncoSec Medical
- Total Funding Total Funding
- Total Rounds 8
- Last Round Post-IPO — $7.0M
-
First Round
First Round
(30 Jun 2011)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2018 | Amount | Post-IPO - OncoSec Medical | Valuation |
investors |
|
| Oct, 2018 | Amount | Post-IPO - OncoSec Medical | Valuation |
investors |
|
| Oct, 2017 | Amount | Post-IPO - OncoSec Medical | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in OncoSec Medical
OncoSec Medical has secured backing from 4 investors, including institutional investors. Prominent investors backing the company include HHS, Sirtex and Grand Pharmaceuticals. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Alpha Chips is engaged in system semiconductor design and services.
|
Founded Year | Domain | Location | |
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location | |
|
Radiation therapy for cancer treatment is developed and provided.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by OncoSec Medical
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - OncoSec Medical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Oncosec Medical Comparisons
Competitors of OncoSec Medical
OncoSec Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, BeiGene, Insitro, BridgeBio and ATAI, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
An AI-enabled platform is developed for infectious disease treatment.
|
|
| domain | founded_year | HQ Location |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| domain | founded_year | HQ Location |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| domain | founded_year | HQ Location |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Oncosec Medical
Frequently Asked Questions about OncoSec Medical
When was OncoSec Medical founded?
OncoSec Medical was founded in 2011.
Where is OncoSec Medical located?
OncoSec Medical is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
How many employees does OncoSec Medical have?
As of Dec 31, 2022, the latest employee count at OncoSec Medical is 26.
What does OncoSec Medical do?
OncoSec Medical was founded in 2011 in San Diego, United States, within the biotechnology sector focused on oncology. Intratumoral immunotherapies are developed using the proprietary ImmunoPulse technology, which applies electroporation to deliver DNA-based therapeutics into tumors and enhance cellular uptake. Lead candidates, including combination therapies for melanoma and IL-12 monotherapy for metastatic melanoma and triple-negative breast cancer, are currently in phase 2 clinical trials.
Who are the top competitors of OncoSec Medical?
OncoSec Medical's top competitors include Jazz Pharmaceuticals, Spark Therapeutics and BridgeBio.
Is OncoSec Medical publicly traded?
Yes, OncoSec Medical is publicly traded on OTC under the ticker symbol ONCSQ.
Who are OncoSec Medical's investors?
OncoSec Medical has 4 investors. Key investors include HHS, Sirtex, Grand Pharmaceuticals, and Alpha Chips.
What is OncoSec Medical's ticker symbol?
The ticker symbol of OncoSec Medical is ONCSQ on OTC.